| Pharmaceutical Information |
| Drug Name |
Oxidronic acid |
| Drug ID |
BADD_D01640 |
| Description |
Not Available |
| Indications and Usage |
Oxidronic acid is a diagnostic skeletal imaging agent used to demonstrate areas of altered osteogenesis in adult and pediatric patients.[L12960] |
| Marketing Status |
approved |
| ATC Code |
Not Available |
| DrugBank ID |
DB14159
|
| KEGG ID |
D05296
|
| MeSH ID |
C029285
|
| PubChem ID |
27304
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
Not Available |
| UNII |
71MR4V32TI
|
| Synonyms |
hydroxymethanediphosphonic acid | hydroxymethanediphosphonic acid, disodium salt | disodium methane hydroxy-diphosphonate | disodium methane-1-hydroxy-1,1-diphosphonate | disodium (hydroxymethylene)diphosphonate | hydroxymethanediphosphonic acid, trisodium salt | hydroxymethanediphosphonic acid, monosodium salt | hydroxymethanediphosphonic acid, tetrasodium salt | hydroxymethanediphosphonic acid, 14C-labeled | hydroxymethylene bisphosphonate | 1,1-hydroxymethyldiphosphonate | MHDP | methylhydroxydiphosphonate |
|
| Chemical Information |
| Molecular Formula |
CH6O7P2 |
| CAS Registry Number |
15468-10-7 |
| SMILES |
C(O)(P(=O)(O)O)P(=O)(O)O |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
